Compare AU
Compare GPEQ vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Global Listed Private Equity ETF (GPEQ) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GPEQ | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $795.59 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,986.71 | $1,695.72 |
Average age group | > 35 | 26 - 35 |
Key Summary
GPEQ | IXJ | |
|---|---|---|
Strategy | GPEQ.AX was created on 2021-11-23 by VanEck. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 39.71m in AUM and 51 holdings. GPEQ.AX gives investors a diversified portfolio of the 50 largest and most liquid global listed private equity companies. GPEQ.AX aims to provide investment returns before fees and other costs which track the performance of the Index. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Blackstone Inc (9.71 %) Apollo Global Management Inc Class A (9.28 %) KKR & Co Inc Ordinary Shares (9.23 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (100.00 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | United States (70.14 %) Switzerland (8.64 %) Sweden (6.30 %) | United States (99.97 %) |
Management fee | 0.65 % | 0.46 % |
Key Summary
GPEQ | IXJ | |
|---|---|---|
Issuer | VanEck | iShares |
Tracking index | LPX 50 Index | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.65 % | 0.46 % |
Price | $25.97 | $139.41 |
Size | $43.162 million | $1.380 billion |
10Y return | N/A | 125.20 % |
Annual distribution yield (5Y) | 1.49 % | 1.26 % |
Market | ASX | ASX |
First listed date | 24/11/2021 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GPEQ | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $795.59 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,986.71 | $1,695.72 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
GPEQ | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GPEQ | IXJ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |